Form 4: HeartBeam Director Jaff Reports Future RSU Grants

HeartBeam Director Michael R. Jaff reported the grant of 78,664 restricted stock units (RSUs) with future vesting dates, alongside current beneficial ownership of 75,120 common shares.

Summary

• Director Michael R. Jaff reported beneficial ownership of 75,120 shares of HeartBeam, Inc. Common Stock.
• Jaff was granted 60,483 Restricted Stock Units (RSUs) on July 11, 2025.
• These 60,483 RSUs will vest 100% on the earlier of July 11, 2026, or the date of HeartBeam's 2026 annual meeting of stockholders, contingent on his continued service as an Outside Director.
• An additional 18,181 Special RSUs were granted on September 30, 2025.
• The 18,181 Special RSUs will vest in two tranches: half on October 1, 2025 (three-month anniversary of July 1, 2025 vesting commencement date) and the remaining half on January 1, 2026 (six-month anniversary).
• All RSUs were issued from the Company's 2022 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: Positive due to alignment of director's interests with shareholders through equity grants, which is a standard and generally favorable practice for corporate governance.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Michael R. Jaff aligns his interests with those of shareholders, incentivizing long-term performance.
• The equity awards are issued under the company's 2022 Equity Incentive Plan, indicating a structured approach to executive compensation.

Negatives

• The issuance of new Restricted Stock Units (RSUs) could lead to a slight dilution of existing shareholder equity upon vesting.

Risks

• Vesting of the 60,483 RSUs is contingent upon Michael R. Jaff continuing to serve as an Outside Director through the applicable vesting date.

Future Outlook

The future outlook for the reporting person's equity holdings is tied to the vesting schedules of the granted Restricted Stock Units, with full vesting for 60,483 RSUs expected by July 11, 2026, and for 18,181 Special RSUs by January 1, 2026, contingent on continued service.

Industry Context

This filing reflects standard practice for public companies to compensate directors with equity, aligning their interests with long-term shareholder value. Such grants are common across various industries as a means of incentivizing leadership and retaining talent.

Comparison to Industry Standards

• Equity compensation for directors, particularly through Restricted Stock Units (RSUs) with vesting conditions tied to continued service, is a widely adopted practice in publicly traded companies across various sectors.
• This approach is consistent with corporate governance best practices aimed at aligning director incentives with long-term company performance and shareholder interests.

Stakeholder Impact

• Shareholders: Potential minor dilution upon RSU vesting, but improved alignment of director's interests with long-term shareholder value.
• Management/Directors: Michael R. Jaff's compensation structure is enhanced with long-term equity incentives.

Next Steps

• Vesting of 60,483 Restricted Stock Units (RSUs) on the earlier of July 11, 2026, or the 2026 annual meeting.
• Vesting of half of the 18,181 Special RSUs on October 1, 2025.
• Vesting of the remaining half of the 18,181 Special RSUs on January 1, 2026.

Key Dates

Recommendation

This Form 4 reports routine equity compensation for a director, which aligns their interests with shareholders but does not provide new fundamental information to alter the investment thesis for HeartBeam, Inc. It is a standard corporate governance practice.

Keywords

HeartBeam, BEAT, Form 4, insider transaction, RSU, restricted stock unit, director compensation, equity incentive plan